特应性皮炎EASI与SCORAD最佳终点:前瞻性观察研究
该前瞻性观察研究纳入826例成人和儿童特应性皮炎患者,采用锚定法确定EASI和SCORAD的百分比与绝对值最小重要变化(MIC)。结果显示EASI 50、SCORAD 35和O-SCORAD 35为不受基线严重度影响的百分比MIC,而绝对值MIC随基线严重度变化。
要点
- EASI 50、SCORAD 35和O-SCORAD 35是跨基线严重度有意义的百分比MIC。
- EASI、SCORAD和O-SCORAD的绝对值MIC随基线严重度显著不同。
- 百分比和绝对值MIC均与症状及生活质量改善相关。
核心结论
- EASI 50、SCORAD 35和O-SCORAD 35是无论基线严重度均有意义的百分比MIC。
- EASI、SCORAD和O-SCORAD的绝对值MIC随基线严重度变化。
研究设计与样本
- 前瞻性皮肤科门诊实践研究,使用问卷和皮肤科医生评估,共纳入826例。
- 采用锚定法确定随访时EASI、SCORAD和O-SCORAD的百分比和绝对值MIC阈值。
主要发现
- PGA和vIGA-AD一级改善分别与EASI下降50%、SCORAD下降35%、O-SCORAD下降35%相关。
关键数值与推荐
- EASI 50、SCORAD 35和O-SCORAD 35为有意义的百分比MIC。
临床怎么用
- 临床实践中可用EASI 50、SCORAD 35或O-SCORAD 35作为跨严重度有意义的百分比改善阈值。
- 使用绝对值MIC时需考虑患者基线严重度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multiple strategies have been used to evaluate the minimal important change (MIC) of the Eczema Area and Severity Index (EASI) and Scoring Atopic Dermatitis (SCORAD). The meaningfulness of these MICs is not well established across all severities of atopic dermatitis (AD). OBJECTIVES: To determine the MIC of percentage and absolute improvement of EASI and SCORAD scores in adults and children with AD. METHODS: We performed a prospective dermatology practice-based study using questionnaires and evaluation by a dermatologist (n = 826). An anchor-based approach was used to determine thresholds for the percentage and absolute MICs of EASI, SCORAD and objective SCORAD (O-SCORAD) at follow-up from baseline. RESULTS: One-grade improvements of Physician's Global Assessment (PGA) and validated Investigator Global Assessment scale for AD (vIGA-AD) were associated with 50%, 35% and 35% decreases of EASI, SCORAD and O-SCORAD, respectively. The thresholds for percentage MIC of EASI (Kruskal-Wallis test, P = 0·61), SCORAD (P = 0·07) and O-SCORAD (P = 0·09) were similar across baseline AD severities. One-grade improvements of PGA and vIGA-AD were associated with 14·0- and 14·9-point decreases of EASI, 19·9- and 14·9-point decreases of SCORAD, and 15·5- and 17·4-point decreases of O-SCORAD. The thresholds for the absolute MIC of EASI (P < 0·001), SCORAD (P < 0·001) and O-SCORAD (P < 0·001) significantly differed by baseline AD severity. Percentage and absolute MICs for EASI and SCORAD were associated with improvements of AD symptoms and quality of life. CONCLUSIONS: EASI 50, SCORAD 35 and O-SCORAD 35 were meaningful percentage MICs regardless of baseline AD severity. The absolute MICs for EASI, SCORAD and O-SCORAD varied by baseline AD severity.
引用
- Silverberg JI, Lei D, Yousaf M, et al. What are the best endpoints for Eczema Area and Severity Index and Scoring Atopic Dermatitis in clinical practice? A prospective observational study. Br J Dermatol. 2020. PMID: 32959390. doi:10.1111/bjd.19457
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。